To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH) (opens ClinicalTrials.gov)
- Sponsor
- ETOP IBCSG Partners Foundation
- Enrolment
- 147
- Started
- 2019-04-16
- Last update
- 2026-10-21
Conditions: Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer
Interventions: Paclitaxel, Trastuzumab, Pertuzumab, Palbociclib…